Molecular Technology in Context: A Current Review of Diagnosis and Management of Infective Endocarditis

Progress in Cardiovascular Diseases

Volumn 50, Issue 3, 2007, Pages 181-197

  Syed, Faisal F ^a   Millar, B Cherie ^b   Prendergast, Bernard D ^c  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COMPLEMENT COMPONENT C3; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINCOMYCIN; MINOCYCLINE; OXACILLIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; ECHOCARDIOGRAPHY; FOLLOW UP; HEART VALVE PROSTHESIS; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MEDICAL RESEARCH; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION;

ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL TYPING TECHNIQUES; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RIBOTYPING; RNA, RIBOSOMAL, 16S; SENSITIVITY AND SPECIFICITY; SEROTYPING;

EID: 35548937784     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2007.08.002     Document Type: Article

References (62)

1. Prendergast B.D. The changing face of infective endocarditis. Heart 92 (2006) 879-885
2. Hoen B. Epidemiology and antibiotic treatment of infective endocarditis: an update. Heart 92 (2006) 1694-1700
3. Beynon R.P., Bahl V.K., and Prendergast B.D. Infective endocarditis. BMJ 333 (2006) 334-339
4. Mylonakis E., and Calderwood S.B. Infective endocarditis in adults. N Engl J Med 345 (2001) 1318-1330
5. Millar B.C., and Moore J.E. Antibiotic prophylaxis, body piercing and infective endocarditis. J Antimicrob Chemother 53 (2004) 123-126
6. Valencia E., and Miro J. Endocarditis in the setting of HIV infection. AIDS Rev 6 (2004) 97-106
7. Tornos P., Iung B., Permanyer-Miralda G., et al. Infective endocarditis in Europe: lessons from the Euro Heart Survey. Heart 91 (2005) 571-575
8. Baddour L.M., Wilson W.R., Bayer A.S., et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111 (2005) e394-e434
9. Olaison L, Pettersson G: Current best practices and guidelines indications for surgical intervention in infective endocarditis. Infect Dis Clin North Am 16: 453-475, xi, 2002
10. Alexiou C., Langley S.M., Stafford H., et al. Surgery for active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg 69 (2000) 1448-1454
11. Thuny F.T., Tribouilloy C.T., Milandre L.M., et al. Cerebrovascular complications of native valve endocarditis: incidence, predictors, and prognosis: a prospective multicenter study. Eur Heart J 27 (2006) 572 Abstract
12. Tornos P., Almirante B., Mirabet S., et al. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med 159 (1999) 473-475
13. Mathew J., Addai T., Anand A., et al. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 155 (1995) 1641-1648
14. Gebo K.A., Burkey M.D., Lucas G.M., et al. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 43 (2006) 426-432
15. Cicalini S., Forcina G., and De Rosa F.G. Infective endocarditis in patients with human immunodeficiency virus infection. J Infect 42 (2001) 267-271
16. Ntsekhe M., and Hakim J. Impact of human immunodeficiency virus infection on cardiovascular disease in Africa. Circulation 112 (2005) 3602-3607
17. Sudano I., Spieker L.E., Noll G., et al. Cardiovascular disease in HIV infection. Am Heart J 151 (2006) 1147-1155
18. Losa J.E., Miro J.M., Del Rio A., et al. Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clin Microbiol Infect 9 (2003) 45-54
19. Zetola N., Francis J.S., Nuermberger E.L., et al. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5 (2005) 275-286
20. Bahrain M., Vasiliades M., Wolff M., et al. Five cases of bacterial endocarditis after furunculosis and the ongoing saga of community-acquired methicillin-resistant Staphylococcus aureus infections. Scand J Infect Dis 38 (2006) 702-707
21. Hsu L.Y., Koh T.H., Tan T.Y., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus in Singapore: a further six cases. Singapore Med J 47 (2006) 20-26
22. Healy C.M., Hulten K.G., Palazzi D.L., et al. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 39 (2004) 1460-1466
23. Crum N.F. The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections. Scand J Infect Dis 37 (2005) 651-656
24. Horstkotte D., Follath F., Gutschik E., et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25 (2004) 267-276
25. Elliott T.S., Foweraker J., Gould F.K., et al. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 54 (2004) 971-981
26. Francioli P., Ruch W., and Stamboulian D. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis 21 (1995) 1406-1410
27. Francioli P., Etienne J., Hoigne R., et al. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA 267 (1992) 264-267
28. Moreillon P., and Que Y.A. Infective endocarditis. Lancet 363 (2004) 139-149
29. Messias-Reason I.J., Hayashi S.Y., Nisihara R.M., et al. Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis. Clin Exp Immunol 127 (2002) 310-315
30. Tran C.T., Kjeldsen K., Haunso S., et al. Mannan-binding lectin is a determinant of survival in infective endocarditis. Clin Exp Immunol 48 (2007) 101-105
31. Heiro M., Helenius H., Sundell J., et al. Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J 26 (2005) 1873-1881
32. Mueller C., Huber P., Laifer G., et al. Procalcitonin and the early diagnosis of infective endocarditis. Circulation 109 (2004) 1707-1710
33. Prendergast B.D. Diagnostic criteria and problems in infective endocarditis. Heart 90 (2004) 611-613
34. Evangelista A., and Gonzalez-Alujas M.T. Echocardiography in infective endocarditis. Heart 90 (2004) 614-617
35. Greaves K., Mou D., Patel A., et al. Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart 89 (2003) 273-275
36. Cabell C.H., and Fowler Jr. V.G. Repeated echocardiography after the diagnosis of endocarditis: too much of a good thing?. Heart 90 (2004) 975-976
37. Von Reyn C.F., Levy B.S., Arbeit R.D., et al. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 94 (1981) 505-518
38. Durack D.T., Lukes A.S., and Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96 (1994) 200-209
39. Habib G., Derumeaux G., Avierinos J.F., et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol 33 (1999) 2023-2029
40. Lamas C.C., and Eykyn S.J. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis 25 (1997) 713-719
41. Fournier P.E., Casalta J.P., Habib G., et al. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med 100 (1996) 629-633
42. Li J.S., Sexton D.J., Mick N., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 (2000) 633-638
43. Lamas C.C., and Eykyn S.J. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart 89 (2003) 258-262
44. Greub G., Lepidi H., Rovery C., et al. Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med 118 (2005) 230-238
45. Raoult D., Casalta J.P., Richet H., et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 43 (2005) 5238-5242
46. Lepidi H., Coulibaly B., Casalta J.P., et al. Autoimmunohistochemistry: a new method for the histologic diagnosis of infective endocarditis. J Infect Dis 193 (2006) 1711-1717
47. Watkin R.W., Lang S., Lambert P.A., et al. The serological diagnosis of staphylococcal infective endocarditis. J Infect 53 (2006) 301-307
48. Millar B.C., and Moore J.E. Current trends in the molecular diagnosis of infective endocarditis. Eur J Clin Microbiol Infect Dis 23 (2004) 353-365
49. Lisby G, Gutschik E, Durack DT: Molecular methods for diagnosis of infective endocarditis. Infect Dis Clin North Am 16: 393-412, x, 2002
50. Goldenberger D., Kunzli A., Vogt P., et al. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 35 (1997) 2733-2739
51. Millar B., Moore J., Mallon P., et al. Molecular diagnosis of infective endocarditis-a new Duke's criterion. Scand J Infect Dis 33 (2001) 673-680
52. Rothman R.E., Majmudar M.D., Kelen G.D., et al. Detection of bacteremia in emergency department patients at risk for infective endocarditis using universal 16S rRNA primers in a decontaminated polymerase chain reaction assay. J Infect Dis 186 (2002) 1677-1681
53. Gauduchon V., Chalabreysse L., Etienne J., et al. Molecular diagnosis of infective endocarditis by PCR amplification and direct sequencing of DNA from valve tissue. J Clin Microbiol 41 (2003) 763-766
54. Grijalva M., Horvath R., Dendis M., et al. Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients. Heart 89 (2003) 263-268
55. Bosshard P.P., Kronenberg A., Zbinden R., et al. Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis 37 (2003) 167-172
56. Podglajen I., Bellery F., Poyart C., et al. Comparative molecular and microbiologic diagnosis of bacterial endocarditis. Emerg Infect Dis 9 (2003) 1543-1547
57. Breitkopf C., Hammel D., Scheld H.H., et al. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation 111 (2005) 1415-1421
58. Rice P.A., and Madico G.E. Polymerase chain reaction to diagnose infective endocarditis: will it replace blood cultures?. Circulation 111 (2005) 1352-1354
59. Rovery C., Greub G., Lepidi H., et al. PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol 43 (2005) 163-167
60. Kotilainen P., Heiro M., Jalava J., et al. Aetiological diagnosis of infective endocarditis by direct amplification of rRNA genes from surgically removed valve tissue. An 11-year experience in a Finnish teaching hospital. Ann Med 38 (2006) 263-273
61. Millar B.C., Xu J., and Moore J.E. Risk assessment models and contamination management: implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology. J Clin Microbiol 40 (2002) 1575-1580
62. Tak T., and Shukla S.K. Molecular diagnosis of infective endocarditis: a helpful addition to the Duke criteria. Clin Med Res 2 (2004) 206-208